NCT07196631View on ClinicalTrials.gov

Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

February 5, 2026

Conditions
Rebound PainLiposomal Bupivacaine
Interventions
DRUG

Liposomal Bupivicaine

patients randomized to the intervention arm received 133mg of liposomal bupivacaine

DRUG

ropivacaine

those in the control group received 80mg of ropivacaine

Trial Locations (2)

430030

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Liu Jiuhong

OTHER